文献速递腹部CTMR

肝脂肪变性对肝细胞癌廓清表现的影响:CT与MRI诊断效能比较

Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
PubMed 文献 · Eur Radiol · 2020-11-07

本回顾性研究纳入566例接受肝切除术的慢性肝病患者(482个肝细胞癌,84个非肝细胞癌),比较脂肪肝组与非脂肪肝组中肝细胞癌廓清表现的出现率及CT与MRI的诊断效能。结果显示,脂肪肝组CT上肝细胞癌廓清表现出现率低于非脂肪肝组(61.5% vs 88.9%),CT诊断敏感度(53.3% vs 80.0%)和准确率(53.9% vs 80.9%)也较低;而MRI两组间廓清表现出现率及诊断效能均无显著差异。

要点

  • 脂肪肝背景下CT上肝细胞癌廓清表现出现率降低(61.5% vs 88.9%),称为「消失的廓清」。
  • 脂肪肝组CT诊断肝细胞癌的敏感度和准确率均低于非脂肪肝组,而MRI两组间无显著差异。
  • 平扫CT肝实质CT值<50 HU时,提示可能出现肝细胞癌廓清表现消失。

核心结论

  • 肝脂肪变性显著降低了CT诊断肝细胞癌的效能,但未显著改变MRI的诊断效能。

研究设计与样本

  • 回顾性研究,纳入2016年1月至2018年6月间接受肝切除术的566例慢性肝病患者(482个肝细胞癌,84个非肝细胞癌),均有动态增强CT和MRI图像。
  • 根据病理检查肝细胞脂滴≥5%将患者分为脂肪肝组(n=141)和非脂肪肝组(n=425)。

关键影像表现/征象

  • 脂肪肝组CT上肝细胞癌廓清表现出现率低于非脂肪肝组(61.5% vs 88.9%,p<0.001)。
  • MRI上肝细胞癌廓清表现出现率在脂肪肝组与非脂肪肝组相似(77.0% vs 74.4%,p=0.565)。

诊断标准与关键数值

  • CT诊断肝细胞癌的敏感度在脂肪肝组低于非脂肪肝组(53.3% vs 80.0%,p<0.001),准确率亦较低(53.9% vs 80.9%,p<0.001)。
  • MRI诊断肝细胞癌的敏感度和准确率在两组间无显著差异(p>0.05)。
  • 平扫CT图像上肝实质CT值<50 HU是肝细胞癌廓清表现消失的最佳截断值。

临床应用与阅片要点

  • 阅片时需注意脂肪肝背景可能掩盖肝细胞癌的廓清表现,导致CT诊断效能下降。
  • 对于脂肪肝患者,MRI可能比CT更可靠地显示肝细胞癌的廓清表现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the presence of washout and the diagnostic performance of computed tomography (CT) and magnetic resonance imaging (MRI) for hepatocellular carcinoma (HCC) according to the presence of hepatic steatosis.

METHODS: This retrospective study included 566 patients with chronic liver disease who had undergone hepatic resection for hepatic tumors (482 HCCs and 84 non-HCCs) between January 2016 and June 2018 and had available multiphasic CT and MR images. Patients were allocated in the fatty liver (n = 141) or non-fatty liver (n = 425) group according to the presence of hepatic steatosis, defined as lipid droplets in at least 5% of hepatocytes on pathological examination. The presence of HCC washout and the diagnostic performance of CT and MRI for HCC were compared between the groups.

RESULTS: HCC washout was less frequently seen in the fatty liver group than in the non-fatty liver group on CT (61.5% vs. 88.9%, p < 0.001), whereas it was similarly present on MRI in both groups (77.0% vs. 74.4%, p = 0.565). For diagnosis of HCC, the sensitivity (53.3% vs. 80.0%, p < 0.001) and accuracy (53.9% vs. 80.9%, p < 0.001) of CT were lower in the fatty liver group than in the non-fatty liver group. However, for MRI, these values were not significantly different between the groups (p > 0.05).

CONCLUSIONS: Hepatic steatosis significantly decreased the performance of CT for the diagnosis of HCC, whereas it did not significantly alter the performance of MRI.

KEY POINTS: • Unlike MRI, there is vanishing HCC washout on CT caused by the background hepatic steatosis. • The diagnostic performance of CT for the diagnosis of HCC was significantly altered by hepatic steatosis. • The optimal cutoff HU value of the liver parenchyma for the vanishing washout of HCC was < 50 HU on unenhanced CT images.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Min JH, Kang TW, Kim YY, et al. Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI. Eur Radiol. 2020. PMID: 33159576. doi:10.1007/s00330-020-07438-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。